Amazon’s $50B OpenAI Investment Tied to AGI Milestone and IPO Plans 
Samsung Electronics Stock Poised for $1 Trillion Valuation Amid AI and Memory Boom 
Meta Signs Multi-Billion Dollar AI Chip Deal With Google to Power Next-Gen AI Models 
Pentagon Weighs Supply Chain Risk Designation for Anthropic Over Claude AI Use 
Boeing Secures $166.8 Million U.S. Navy Contract for P-8A Engineering and Software Support 
Coupang Reports Q4 Loss After Data Breach, Revenue Misses Estimates 
DeepSeek AI Model Trained on Nvidia Blackwell Chip Sparks U.S. Export Control Concerns 
Nintendo Share Sale: MUFG and Bank of Kyoto to Sell Stakes in Strategic Unwinding 
Trump Orders Federal Agencies to Halt Use of Anthropic AI Technology 
OpenAI Targets $600B Compute Spend as IPO Valuation Could Reach $1 Trillion 
OpenAI Pentagon AI Contract Adds Safeguards Amid Anthropic Dispute 
Trump Pushes Tech Giants to Build Power Plants to Offset AI Data Center Energy Costs 
Anthropic Refuses Pentagon Request to Remove AI Safeguards Amid Defense Contract Dispute 
Middle East Airspace Shutdown Disrupts Global Flights After U.S.-Israel Strikes on Iran 
FCC Approves Charter Communications’ $34.5 Billion Acquisition of Cox Communications 
Lynas Rare Earths Shares Surge on Strong Half-Year Earnings and Rising Global Demand 
Netflix Declines to Raise Bid for Warner Bros. Discovery Amid Competing Paramount Skydance Offer 
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
